Companies similar to ATRIUM THERAPEUTICS INC (RNA)
Health Care · NASDAQ
ATRIUM THERAPEUTICS INC (RNA)'s closest peers include ARROWHEAD PHARMACEUTICALS, INC. (ARWR), Alnylam Pharmaceuticals (ALNY), Ionis Pharmaceuticals (IONS) and Regeneron Pharmaceuticals (REGN). This peer set is drawn from RNA's enriched company profile and is informational only — not financial advice.
Similar companies
-
ARROWHEAD PHARMACEUTICALS, INC.ARWRHealth Care
A clinical-stage RNA interference biotech transitioning to commercial revenue through targeted gene-silencing therapeutics.
$71.38 (as of 2026-07-16) · market cap $9.9B
-
Alnylam PharmaceuticalsALNYHealth Care
A commercial-stage RNAi therapeutics pioneer with six FDA-approved siRNA medicines targeting rare genetic and cardiometabolic diseases.
$283.15 (as of 2026-07-16) · market cap $37.2B
-
Ionis PharmaceuticalsIONSHealth Care
Pioneer in RNA-targeted antisense medicines with seven commercialized products and expanding late-stage pipeline across rare neurological and cardiometabolic…
$54.65 (as of 2026-07-16) · market cap $9.0B
-
Regeneron PharmaceuticalsREGNHealth Care
Regeneron develops and commercializes monoclonal antibody and other biologics therapies across immunology, oncology, infectious disease, and other therapeutic…
$678.94 (as of 2026-07-16) · market cap $70.5B
Not quite? Describe exactly what you want →
Peers are drawn from RNA's enriched profile (the same similarity signal the chat uses for "companies like RNA"). See the full profile: ATRIUM THERAPEUTICS INC (RNA).
Last updated 2026-07-16.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.